139 related articles for article (PubMed ID: 6290930)
21. Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
Hildebrand J; Gangji D; Nouwynck C; Machin D
Cancer Treat Rep; 1977 Dec; 61(9):1695-8. PubMed ID: 74284
[No Abstract] [Full Text] [Related]
22. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
Paoletti P; Robustelli della Cuna G; Knerich R; Strada MR
Acta Neurochir (Wien); 1978; 41(4):287-99. PubMed ID: 356524
[TBL] [Abstract][Full Text] [Related]
23. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
[TBL] [Abstract][Full Text] [Related]
24. [The chemotherapy of tumors of the central nervous system (author's transl)].
Paoletti P
Riv Patol Nerv Ment; 1976; 96(1):19-34. PubMed ID: 183261
[TBL] [Abstract][Full Text] [Related]
25. Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies.
El-Yazigi A; Martin CR
Pharm Res; 1988 Apr; 5(4):220-5. PubMed ID: 3247301
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors.
Fewer D; Wilson CB; Boldrey EB; Enot JK
Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504
[TBL] [Abstract][Full Text] [Related]
27. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
28. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow grafts in dogs treated with lethal doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Abb J; Netzel B; Rodt HV; Thierfelder S
Cancer Res; 1978 Jul; 38(7):2157-9. PubMed ID: 350384
[TBL] [Abstract][Full Text] [Related]
30. Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients.
Wolff JE; Berrak S; Koontz Webb SE; Zhang M
J Neurooncol; 2008 May; 88(1):57-63. PubMed ID: 18253699
[TBL] [Abstract][Full Text] [Related]
31. Treatment of malignant gliomas in adults with BCNU plus metronidazole.
Stewart DJ; Benoit B; Richard MT; Hugenholtz H; Dennery J; Russell N; Peterson E; Grahovac Z; Belanger G; Maroun JA
J Neurooncol; 1984; 2(1):53-8. PubMed ID: 6088725
[TBL] [Abstract][Full Text] [Related]
32. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Raizer JJ; Malkin MG; Kleber M; Abrey LE
Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
[TBL] [Abstract][Full Text] [Related]
33. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Brajtburg J; Elberg S; Schechtman KB; Medoff G
Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
[TBL] [Abstract][Full Text] [Related]
34. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
Walker MD; Alexander E; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Norrell HA; Owens G; Ransohoff J; Wilson CB; Gehan EA; Strike TA
J Neurosurg; 1978 Sep; 49(3):333-43. PubMed ID: 355604
[TBL] [Abstract][Full Text] [Related]
36. [Nitrosourea-induced lung diseases].
Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas.
Weir B; Band P; Urtasun R; Blain G; Mclean D; Wilson F; Mielke B; Grace M
J Neurosurg; 1976 Aug; 45(2):129-34. PubMed ID: 939970
[TBL] [Abstract][Full Text] [Related]
38. Theophylline-induced lomustine toxicity.
Zeltzer PM; Feig SA
Lancet; 1979 Nov; 2(8149):960-1. PubMed ID: 91053
[No Abstract] [Full Text] [Related]
39. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
[TBL] [Abstract][Full Text] [Related]
40. Controlled study of CCNU and radiation therapy in malignant astrocytoma.
Reagan TJ; Bisel HF; Childs DS; Layton DD; Rhoton AL; Taylor WF
J Neurosurg; 1976 Feb; 44(2):186-90. PubMed ID: 173814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
